Lukas Perkhofer

2.4k total citations
55 papers, 955 citations indexed

About

Lukas Perkhofer is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Lukas Perkhofer has authored 55 papers receiving a total of 955 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 16 papers in Surgery. Recurrent topics in Lukas Perkhofer's work include Pancreatic and Hepatic Oncology Research (26 papers), Cancer Genomics and Diagnostics (14 papers) and Cancer Cells and Metastasis (6 papers). Lukas Perkhofer is often cited by papers focused on Pancreatic and Hepatic Oncology Research (26 papers), Cancer Genomics and Diagnostics (14 papers) and Cancer Cells and Metastasis (6 papers). Lukas Perkhofer collaborates with scholars based in Germany, United States and Netherlands. Lukas Perkhofer's co-authors include Alexander Kleger, Thomas Seufferlein, Thomas J. Ettrich, Martin C. Müller, Johann Gout, Élodie Roger, Stefan Liebau, Carolina Simões, Fernando Kude de Almeida and Lisa Wiesmüller and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Lukas Perkhofer

52 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lukas Perkhofer Germany 18 551 360 270 231 158 55 955
Zhe Su China 16 314 0.6× 307 0.9× 343 1.3× 150 0.6× 169 1.1× 42 857
Hongfeng Gou China 13 447 0.8× 335 0.9× 190 0.7× 165 0.7× 130 0.8× 60 968
Hideaki Kinugasa Japan 20 531 1.0× 447 1.2× 470 1.7× 255 1.1× 280 1.8× 64 1.2k
Yoshihiro Nakazato Japan 14 643 1.2× 287 0.8× 191 0.7× 244 1.1× 137 0.9× 30 1.2k
Yifeng Zou China 22 610 1.1× 408 1.1× 211 0.8× 261 1.1× 176 1.1× 67 1.2k
Lorraine A. Chantrill Australia 14 605 1.1× 185 0.5× 206 0.8× 246 1.1× 170 1.1× 48 885
Yongfu Xiong China 19 254 0.5× 516 1.4× 312 1.2× 102 0.4× 211 1.3× 56 1.0k
Xi Cheng China 13 262 0.5× 251 0.7× 191 0.7× 283 1.2× 138 0.9× 30 923
Alexandra Pohl United States 15 539 1.0× 332 0.9× 196 0.7× 208 0.9× 243 1.5× 20 1.1k
Masaya Hiyoshi Japan 18 376 0.7× 652 1.8× 472 1.7× 167 0.7× 138 0.9× 45 1.2k

Countries citing papers authored by Lukas Perkhofer

Since Specialization
Citations

This map shows the geographic impact of Lukas Perkhofer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Perkhofer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Perkhofer more than expected).

Fields of papers citing papers by Lukas Perkhofer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Perkhofer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Perkhofer. The network helps show where Lukas Perkhofer may publish in the future.

Co-authorship network of co-authors of Lukas Perkhofer

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas Perkhofer. A scholar is included among the top collaborators of Lukas Perkhofer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas Perkhofer. Lukas Perkhofer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seufferlein, Thomas, Ludwig Lausser, Alexander Stein, et al.. (2024). Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal cancer—Results of the prospective multicenter PERMAD trial. PLoS ONE. 19(6). e0304324–e0304324.
2.
Schirge, Silvia, Johann Gout, Frank Arnold, et al.. (2023). TBX3 is dynamically expressed in pancreatic organogenesis and fine-tunes regeneration. BMC Biology. 21(1). 55–55. 1 indexed citations
3.
Ettrich, Thomas J., et al.. (2022). Pancreatic Cancer: Current Multimodality Treatment Options and the Future Impact of Molecular Biological Profiling. Visceral Medicine. 38(1). 20–29. 9 indexed citations
4.
Hüttner, Felix J., et al.. (2022). Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions. Cancers. 14(22). 5580–5580. 25 indexed citations
5.
Perkhofer, Lukas, Martin Wagner, Bernd Mayer, et al.. (2022). The impact of endoscopic activity on musculoskeletal disorders of high-volume endoscopists in Germany. Scientific Reports. 12(1). 8538–8538. 8 indexed citations
6.
Merkle, Jessica, Markus Breunig, Jana Krüger, et al.. (2021). CDKN2A-Mutated Pancreatic Ductal Organoids from Induced Pluripotent Stem Cells to Model a Cancer Predisposition Syndrome. Cancers. 13(20). 5139–5139. 15 indexed citations
7.
Seufferlein, Thomas, Waldemar Uhl, Hana Algül, et al.. (2021). LBA56 Perioperative or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Results of the NEONAX trial, a randomized phase II AIO study. Annals of Oncology. 32. S1333–S1333. 5 indexed citations
8.
Perkhofer, Lukas, Detlef Michel, Andreas W. Rost, et al.. (2021). COVID-19-Pandemie-bedingte Belastungen und SARS-CoV-2-Prävalenz in Pflegeeinrichtungen. Zeitschrift für Gerontologie und Geriatrie. 54(5). 463–470. 2 indexed citations
9.
10.
Arnold, Frank, Georg Beyer, Frank Ulrich Weiß, et al.. (2020). Serum IgG4 levels outperform IgG4/IgG RNA ratio in differential diagnosis of IgG4-related disease. JHEP Reports. 2(4). 100135–100135. 1 indexed citations
11.
Seufferlein, Thomas, et al.. (2018). IgG4-Related Diseases in the Gastrointestinal Tract: Clinical Presentation, Diagnosis and Treatment Challenges. Digestion. 100(1). 1–14. 9 indexed citations
12.
Finkelmeier, Fabian, Carolin Czauderna, Lukas Perkhofer, et al.. (2018). Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers. Journal of Cancer Research and Clinical Oncology. 145(1). 253–259. 37 indexed citations
13.
Berger, Andreas W., Cord Langner, Leopold Ludwig, et al.. (2017). Genetic Biopsy for Prediction of Surveillance Intervals after Endoscopic Resection of Colonic Polyps: Results of the GENESIS Study. United European Gastroenterology Journal. 6(2). 290–299. 5 indexed citations
14.
Hohwieler, Meike, Lukas Perkhofer, Stefan Liebau, et al.. (2016). Stem cell‐derived organoids to model gastrointestinal facets of cystic fibrosis. United European Gastroenterology Journal. 5(5). 609–624. 17 indexed citations
15.
Perkhofer, Lukas, Karolin Walter, Ivan G. Costa, et al.. (2016). Tbx3 fosters pancreatic cancer growth by increased angiogenesis and activin/nodal-dependent induction of stemness. Stem Cell Research. 17(2). 367–378. 29 indexed citations
16.
Müller, Martin C., Patrick Hermann, Stefan Liebau, et al.. (2016). The role of pluripotency factors to drive stemness in gastrointestinal cancer. Stem Cell Research. 16(2). 349–357. 72 indexed citations
17.
Ettrich, Thomas J., Lukas Perkhofer, Goetz von Wichert, et al.. (2016). DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma. BMC Cancer. 16(1). 21–21. 15 indexed citations
18.
Müller, Martin C., Thomas Seufferlein, Lukas Perkhofer, Martin Wagner, & Alexander Kleger. (2015). Self-Expandable Metal Stents for Persisting Esophageal Variceal Bleeding after Band Ligation or Injection-Therapy: A Retrospective Study. PLoS ONE. 10(6). e0126525–e0126525. 14 indexed citations
19.
Perkhofer, Lukas, Thomas J. Ettrich, & T Seufferlein. (2014). Pancreatic Cancer: Progress in Systemic Therapy. PubMed. 1(4). 167–179. 9 indexed citations
20.
Kleger, Alexander, Lukas Perkhofer, & Thomas Seufferlein. (2014). Smarter drugs emerging in pancreatic cancer therapy. Annals of Oncology. 25(7). 1260–1270. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhe Su Breakdown of academic impact, for papers by Hongfeng Gou Breakdown of academic impact, for papers by Hideaki Kinugasa Breakdown of academic impact, for papers by Yoshihiro Nakazato Breakdown of academic impact, for papers by Yifeng Zou Breakdown of academic impact, for papers by Lorraine A. Chantrill Breakdown of academic impact, for papers by Yongfu Xiong Breakdown of academic impact, for papers by Xi Cheng Breakdown of academic impact, for papers by Alexandra Pohl Breakdown of academic impact, for papers by Masaya Hiyoshi
Rankless by CCL
2026